Daniel Shao Weng Tan
CIK: 0002113926
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HCM
HUTCHMED (China) Ltd
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Tan Daniel Shao Weng
Tan Daniel Shao Weng (SEC CIK 0002113926) files insider reports with the SEC as Director of HUTCHMED (China) Ltd (HCM).
Signal8 holds 1 ownership filing by Tan Daniel Shao Weng, a Form 3, filed on Mar 10, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Tan Daniel Shao Weng's filings is in HONG KONG, K3.
Other insiders filing for HUTCHMED (China) Ltd (HCM)
- Cheng Chig Fung, Chief Financial Officer
- Nixon Charles George Rupert, Group General Counsel
- Su Wei-guo, CEO and CSO
- Chiu Lorenso, Deputy Chief Financial Officer
- Mok Tony Shu Kam, Director
- Yang Ling, Director